Stockscreener 앱 받기
1.71
4.47%
-0.08
InspireMD Inc. 주식(NSPR)의 최신 뉴스
InspireMD revenue up 62% to USD 3.1M in Q4 2025 - Medical Buyer
Returns Recap: Can InspireMD Inc outperform in the next rallyDay Trade & Safe Entry Trade Reports - baoquankhu1.vn
InspireMD’s Growth Hinges on Real CAS Market Size and Physician Adoption - TipRanks
InspireMD Reports 62% Q4 Revenue Growth and Sets 2026 Outlook for CGuard Prime Carotid Stent System - Minichart
InspireMD tops Q4 estimates as revenue jumps, shares rise in premarket trading - MSN
InspireMD earnings beat by $0.05, revenue topped estimates - Investing.com Canada
InspireMD, Inc. (NSPR) Posts Fourth Quarter Loss, Surpasses Revenue Projections - Bitget
InspireMD Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: InspireMD Q4 2025: Revenue Surges, EPS Beats - Investing.com
InspireMD, Inc. Overview: CGuard Carotid Stent Technology, Business Strategy, and Market Leadership in Stroke Prevention 72 - Minichart
InspireMD Reports Strong Q4 2025 Growth and Expansion - TipRanks
FDA PMA and global expansion reshape InspireMD (NSPR) carotid focus - Stock Titan
InspireMD, Inc. (NSPR) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
InspireMD, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
InspireMD Q4 net income USD -11.761 million - marketscreener.com
InspireMD Reports Fourth Quarter and Full Year 2025 Financial Results - Bitget
INSPIREMD ($NSPR) Releases Q4 2025 Earnings - Quiver Quantitative
[8-K] InspireMD, Inc. Reports Material Event | NSPR SEC FilingForm 8-K - Stock Titan
InspireMD Q4 revenue rises 62%, beats estimates - TradingView
Stroke stent maker InspireMD lifts sales 62% and targets up to $15M in 2026 - Stock Titan
921,587 Shares in InspireMD, Inc. $NSPR Purchased by Ghisallo Capital Management LLC - MarketBeat
Stock Recap: Is InspireMD Inc a momentum stockQuarterly Trade Report & Safe Capital Investment Plans - baoquankhu1.vn
Rosalind Advisors Inc. Purchases 1,616,644 Shares of InspireMD, Inc. $NSPR - MarketBeat
InspireMD (NSPR) price target increased by 25.00% to 5.10 - MSN
Aug Opening: Can InspireMD Inc outperform in the next rally2026 Analyst Calls & Low Drawdown Trading Techniques - baoquankhu1.vn
Aug PreEarnings: Is InspireMD Inc stock risky to hold now2026 Short Interest & Weekly Top Stock Performers List - baoquankhu1.vn
InspireMD, Inc. Scheduled to Release Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026 - Quiver Quantitative
InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Carotid stent developer InspireMD sets March 18 results call - Stock Titan
InspireMD (NSPR) price target decreased by 11.11% to 4.08 - MSN
Is InspireMD Inc. stock dividend yield sustainableWeekly Risk Report & Verified Momentum Watchlists - Naître et grandir
InspireMD Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
InspireMD Announces Planned Departure of Chief Operating Officer - TipRanks
InspireMD announces dismissal of chief operating officer Andrea Tommasoli By Investing.com - Investing.com South Africa
InspireMD announces dismissal of chief operating officer Andrea Tommasoli - Investing.com
Embolic Protection Devices Market to Reach USD 1,161.31 Million by 2032, Growing at a CAGR of 7.58% | DelveInsight - Barchart.com
InspireMD dismisses COO Andrea Tommasoli; last day expected Sept 1, 2026 - TradingView
InspireMD (NSPR) outlines COO dismissal, French-law notice and €61k severance - Stock Titan
InspireMD, Inc. Announces Dismissal of Chief Operating Officer Andrea Tommasoli, Effective April 1, 2026 - marketscreener.com
Tangible book value per share of InspireMD Inc. – LSX:A3CMP3 - TradingView
NSPR Technical Analysis & ETF Price Forecast - Intellectia AI
Can InspireMD Inc. outperform in the next rallyJuly 2025 Market Mood & AI Powered Buy and Sell Recommendations - mfd.ru
NSPR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Stock Report: Why is InspireMD Inc stock going upEarnings Growth Summary & Daily Chart Pattern Signal Reports - baoquankhu1.vn
InspireMD (NSPR) Price Target Increased by 25.00% to 5.10 - Nasdaq
Lake Street reiterates InspireMD stock rating citing market growth By Investing.com - Investing.com Canada
Director adds 2,710 InspireMD (NSPR) shares in amended Form 4 - Stock Titan
What hedge fund activity signals for InspireMD Inc. stock2025 Growth vs Value & Detailed Earnings Play Strategies - mfd.ru
Aberdeen Group plc Makes New Investment in InspireMD, Inc. $NSPR - Defense World
Can InspireMD Inc. ride the EV wavePortfolio Growth Summary & Free AI Powered Buy and Sell Recommendations - mfd.ru
Is InspireMD Inc. stock a top momentum playJuly 2025 Highlights & Weekly Breakout Stock Alerts - mfd.ru
How InspireMD Inc. stock performs in interest rate cyclesEarnings Growth Summary & Weekly High Return Stock Opportunities - mfd.ru
OrbiMed discloses sizable passive stake in InspireMD (NSPR) common stock - Stock Titan
NSPR PE Ratio & Valuation, Is NSPR Overvalued - Intellectia AI
What is InspireMD Inc. s debt to equity ratioJuly 2025 Trends & Accurate Intraday Trading Signals - mfd.ru
Is InspireMD Inc. stock a contrarian buyJuly 2025 Decliners & Community Consensus Trade Signals - mfd.ru
Will InspireMD Inc. stock see PE expansionJuly 2025 Setups & Community Verified Swing Trade Signals - mfd.ru
Will InspireMD Inc. stock hit new highs in YEAR2025 Stock Rankings & Daily Profit Focused Stock Screening - mfd.ru
Rosalind funds disclose 9.2% InspireMD (NSPR) stake with warrant blocker - Stock Titan
Aberdeen Group plc Expands Stake in InspireMD Inc with Strategic Acquisition - GuruFocus
Gains Report: Why is InspireMD Inc stock going upMarket Trend Summary & Daily Price Action Insights - baoquankhu1.vn
This Insider Has Just Sold Shares In InspireMD - simplywall.st
0.85%
1.86%
자본화:
|
볼륨(24시간):